The Drugs Controller General of India (DCGI) in February granted approval to the single-shot Sputnik Light vaccine for restricted use in em...

Hyderabad-based Dr. Reddy's Laboratories had presented its proposal to DCGI for conducting the phase-3 trial of Sputnik Light vaccine as bo...

The standalone Sputnik Light vaccine is the latest jab to be approved by the DCGI as part of India's national inoculation effort against CO...

"We feel confident that Sputnik Light is not only effective against other variants of concern, but also with Omicron,” MV Ramana, CEO, Bran...

Sputnik V is a two-dose vaccine made from two components - recombinant adenovirus 26 or Ad26 and adenovirus 5 or Ad5 The first dose (Ad26) ...

Gamaleya said it expects Sputnik V to provide a strong defence against severe disease and hospitalisation, as the drop in neutralising acti...

In April 2021, India had granted an emergency use authorisation for Sputnik V. RDIF said its Sputnik V has been authorised in 71 countries ...

Addressing a press conference, the CEO of Russian Direct Investment Fund Kirill Dmitriev said, "We are hopeful for the launch of Sputnik li...

As per RDIF, Sputnik Light has been authorized in more than 15 countries. Gland Pharma said it is focusing on rolling out the single shot S...

The Russian ambassador had urged the Indian government to allow the export of Sputnik Light produced by Hetero Biopharma, one of the partne...

After launching Sputnik V, Russia introduced a new single-dose vaccine, called Sputnik Light, in May. As in the case of Sputnik, Sputnik Li...

The Mumbai-based firm has entered into an agreement with Enso and Human Vaccine LLC , a wholly owned unit of the management company of RDIF...

"Delta cases surge in US & Israel shows mRNA vaccines need a heterogeneous booster to strengthen & prolong immune response. #SputnikV pione...

In September 2020, the company partnered with RDIF to conduct the clinical trials of Sputnik V and distribute the vaccine in India. The Hyd...

Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF, a joint ...

Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually.

If approved Sputnik would become the first non-Western coronavirus jab to be certified for use across the 27-nation bloc.